Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB Cause Contraindicated product administered? 95 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Contraindicated product administered have been filed in association with ERENUMAB (AIMOVIG). This represents 8.0% of all adverse event reports for ERENUMAB.

95
Reports of Contraindicated product administered with ERENUMAB
8.0%
of all ERENUMAB reports
89
Deaths
82
Hospitalizations

How Dangerous Is Contraindicated product administered From ERENUMAB?

Of the 95 reports, 89 (93.7%) resulted in death, 82 (86.3%) required hospitalization, and 83 (87.4%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB. However, 95 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB Cause?

Off label use (293) Migraine (285) Drug ineffective (280) Gastrooesophageal reflux disease (236) Drug intolerance (227) Vomiting (220) Pain (217) Abdominal pain upper (210) Blepharospasm (209) Hypoaesthesia (204)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which ERENUMAB Alternatives Have Lower Contraindicated product administered Risk?

ERENUMAB vs ERENUMAB-AOOE ERENUMAB vs ERENUMAB\ERENUMAB-AOOE ERENUMAB vs ERGOCALCIFEROL ERENUMAB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB vs ERIBULIN

Related Pages

ERENUMAB Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered ERENUMAB Demographics